Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Togashi

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
JAMA Oncology|October 15, 2020
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical TrialHidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami, et al.
Cancer Science|August 9, 2024
Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)Takuya Fujimoto, Osamu Yamasaki, Noriyuki Kanehira, et al.
Molecular Oncology|May 22, 2026
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancerJun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironmentShusuke Kawashima, Takashi Inozume, Masahito Kawazu, et al.
Internal Medicine (Tokyo, Japan)|May 21, 2025
A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion: A Case ReportTakahiro Baba, Hirofumi Inoue, Hiromi Matsuoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapyToshifumi Ninomiya, Caiyang Fang, Hirofumi Hamano, et al.
Cancer Science|June 2, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse ModelTakaaki Tanaka, Masato Fujitani, Masataka Taoka, et al.
Blood Cancer Discovery|October 18, 2021
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1Junji Koya, Yuki Saito, Takuro Kameda, et al.
British Journal of Cancer|June 4, 2024
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancerYuichiro Tsukada, Hideaki Bando, Koji Inamori, et al.
Scientific Reports|January 12, 2021
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimensYukie Kashima, Yosuke Togashi, Shota Fukuoka, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
JAMA Oncology|October 15, 2020
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical TrialHidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami, et al.
Cancer Science|August 9, 2024
Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)Takuya Fujimoto, Osamu Yamasaki, Noriyuki Kanehira, et al.
Molecular Oncology|May 22, 2026
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancerJun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironmentShusuke Kawashima, Takashi Inozume, Masahito Kawazu, et al.
Internal Medicine (Tokyo, Japan)|May 21, 2025
A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion: A Case ReportTakahiro Baba, Hirofumi Inoue, Hiromi Matsuoka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapyToshifumi Ninomiya, Caiyang Fang, Hirofumi Hamano, et al.
Cancer Science|June 2, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse ModelTakaaki Tanaka, Masato Fujitani, Masataka Taoka, et al.
Blood Cancer Discovery|October 18, 2021
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1Junji Koya, Yuki Saito, Takuro Kameda, et al.
British Journal of Cancer|June 4, 2024
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancerYuichiro Tsukada, Hideaki Bando, Koji Inamori, et al.
Scientific Reports|January 12, 2021
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimensYukie Kashima, Yosuke Togashi, Shota Fukuoka, et al.
Pageof 16